Alcon Biosciences Private Limited

Alcon Biosciences Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24230MH1982PTC026953 Incorporated 19 April 1982 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma MSME
Data last updated
Revenue · FY 2025
₹125.22 Cr
▲ 10% YoY
Net profit · FY 2025
₹9.57 Cr
Net margin 7.6%
EBITDA · FY 2025
₹15.23 Cr
EBITDA margin 12.2%
Authorised capital
₹1.1 Cr
Registered with MCA
Paid-up capital
₹1.03 Cr
Issued & subscribed
Open charges
₹24.22 Cr
Satisfied ₹37.16 Cr
Company age
44 yrs
Est. 1982
Employees · EPFO
108
Provident fund records

About Alcon Biosciences Private Limited

Data last updated:

Alcon Biosciences Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 19 April 1982 and has been in existence for over 44 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1982PTC026953. Its GSTIN is 27AAACA5119P1ZH (Maharashtra). The company holds 2 GST registrations, all of them active.

The company has an authorised share capital of ₹1.1 Cr and a paid-up capital of ₹1.03 Cr. It was formerly known as Alcon Pharamaceuticals Private Limited. It is led by directors including Advait Jajodia and Ashutosh Radheshyam Tripathi.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 112 Marine Chambers 11 New Marine Lines, Mumbai, Maharashtra, India – 400020.

As per the financials filed for FY 2025, the company reported a revenue of ₹125.22 Cr, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹9.57 Cr (net margin 7.6%) and EBITDA of ₹15.23 Cr (EBITDA margin 12.2%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 7% over five years.

The company has about 108 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Alcon Biosciences. As per MCA filings, the company has open charges of ₹24.22 Cr and satisfied charges of ₹37.16 Cr on record. Court records list 13 cases involving the company, including 11 filed by the company and 2 filed against it; 4 cases are pending. The company has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹2.55 Cr; the latest was in March 2017. Its 8 peer companies in the Pharma industry (API Manufacturers, Biosciences), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is Coral Drugs Private Limited with revenue of ₹126.9 Cr. The company has 11 MSME Form 1 returns on record between 2019 and 2024, listing 1,044 overdue payments to 111 micro and small suppliers.

Alcon Biosciences Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-GJ-25-0007199). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website alconpharma.com.

Company details

CIN U24230MH1982PTC026953
Registration Number 026953
Incorporation Date 19 April 1982
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-GJ-25-0007199

Recognitions & Rankings of Alcon Biosciences

MSME (Udyam registered) Ministry of MSME
Udyam number
UDYAM-GJ-25-0007199

Contact details

Alcon Biosciences Private Limited's registered office is in Mumbai, Maharashtra. Its website is alconpharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    112 Marine Chambers 11 New Marine Lines, Mumbai, Maharashtra, India – 400020
  • Industry
    Pharma, API Manufacturers

To see the full contact details of Alcon Biosciences Private Limited, buy the company report.

Comprehensive company report
Alcon Biosciences Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Alcon Biosciences operates one associated brand: Alcon Biosciences. Each brand links to its own profile.

BrandDescriptionWebsite
CDMO focused on manufacturing of APIalconpharma.com

Business activity

The main business activity of Alcon Biosciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Alcon Biosciences Private Limited, buy the company report.

Financials of Alcon Biosciences Private Limited

FY 2025 filings available

Alcon Biosciences Private Limited reported revenue of ₹125.22 Cr (up 10% YoY) for FY 2025.

Revenue · FY 2025
₹125.22 Cr ▲ 10%
Net profit · FY 2025
₹9.57 Cr margin 7.6%
EBITDA · FY 2025
₹15.23 Cr margin 12.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 10%
3 years · compounded
▲ 1%
5 years · compounded
▲ 7%
EBITDA CAGR growth
1 year
▲ 86%
3 years · compounded
▲ 7%
5 years · compounded
▲ 7%

Revenue has grown at a compounded annual rate (CAGR) of 7% over five years, including 10% growth in the latest year. EBITDA rose 86% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹15.23 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹9.57 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin12.2%
Net Profit Margin7.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Alcon Biosciences Private Limited, buy the company report.

Board of directors of Alcon Biosciences Private Limited

Alcon Biosciences has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Advait JajodiaDirector24 Jun 20233 Years 4 MonthsCurrent
Ashutosh Radheshyam TripathiDirector01 Sep 20251 Years 1 MonthsCurrent
Vishal Narayanprasad JajodiaDirector07 Dec 200322 Years 10 MonthsCurrent

Peer comparison

Alcon Biosciences Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (API Manufacturers, Biosciences), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Coral Drugs Private Limited₹126.9 Cr (FY 2025)11.0%New Delhi, Delhi, India
Sohan Healthcare Private Limited₹126.69 Cr (FY 2025)6.0%Yavatmal, Maharashtra, India
Corey Organics Private Limited₹126.33 Cr (FY 2025)-6.0%Hyderabad, Telangana, India
Smruthi Organics Ltd₹126.1 Cr (FY 2025)-1.0%Solapur, Maharashtra, India
Alcon Biosciences Private Limitedthis company₹125.22 Cr (FY 2025)₹9.57 Cr7.6%10.0%108Mumbai, Maharashtra, India
Quad Lifesciences Private Limited₹123.66 Cr (FY 2025)26.0%Derabassi, Punjab, India
Roopa Industries Limited₹122.98 Cr (FY 2025)72.0%Kurnool, A.P, Andhra Pradesh, India
Richter Themis Medicare (India) Private Limited₹122.69 Cr (FY 2025)-13.0%Valsad, Gujarat, India
Nuray Chemicals Private Limited₹122.27 Cr (FY 2025)16.0%Thiruvallur, Tamil Nadu, India

To see the full peer comparison of Alcon Biosciences Private Limited, buy the company report.

Auditor

Alcon Biosciences Private Limited is audited by Vinod S. Mehta & Co. for the financial year 2024.

Auditor firmFinancial yearFirm registration number
Vinod S. Mehta & Co.FY 2024111524W

Shareholding

The shareholding of Alcon Biosciences Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Alcon Biosciences Private Limited, buy the company report.

Charges & borrowings

Open charges
₹24.22 Cr
Satisfied charges
₹37.16 Cr
Breakdown by lending institutions
Others₹21.52 Cr
Hdfc Bank Limited₹2.70 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
30 Aug 2022100609238Hdfc Bank Limited₹2.7 CrOpen
11 Jan 2022100530433Others₹2.41 CrOpen
27 Jun 199890229362Others₹19.11 CrOpen
04 Jan 201110265344Union Bank of India₹20.96 CrSatisfied
10 Oct 200910188646Union Bank of India₹14.5 CrSatisfied

To see the full charge records of Alcon Biosciences Private Limited, buy the company report.

Total charge records: 7 View all charges

Deals & funding

Alcon Biosciences Private Limited has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹2.55 Cr; the latest was in March 2017.

Total deals
3
Secondary share transfers
2
Funding round
1
Disclosed funding
₹2.55 Cr

Deals on record (3 of 3)

WhenDealAmountParties
Mar 2017Secondary share transferUndisclosedBuyer: an individual
Seller: Arpita Tradelink Private Limited , Andhan Trade Link Private Limited, Hemang Fincap Services Private Limited
Mar 2013Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Mar 2012Funding round₹2.55 CrInvestors: Lark Chemicals Private Limited , Hemang Fincap Services Private Limited , Andhan Trade Link Private Limited

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Alcon Biosciences Private Limited was last rated by Crisil on 16 Mar 2020.

Rating agencyRated onRating
Crisil16 Mar 2020

To see the full credit ratings and regulatory alerts of Alcon Biosciences Private Limited, buy the company report.

MSME payment delays

Alcon Biosciences Private Limited has 11 MSME Form 1 returns on record between 2019 and 2024, listing 1,044 overdue payments to 111 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 111)

SupplierAmount dueDue sinceReported on
Shah Chemical
an individual supplier
Prachin Chemical
Sohan Healthcare Private Limited
Dayaram Chemicals Private Limited

To see the full MSME payment records of Alcon Biosciences Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Alcon Biosciences Private Limited has a workforce of 108 employees on its EPFO records as of Nov 25, 2024, across 1 active EPFO establishment.

Employee count
108
Active EPFO establishments
1
Employee growth
3.85%

GST

Alcon Biosciences has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
27AAACA5119P1ZHMaharashtraActive01 Jul 2017
24AAACA5119P1ZNGujaratActive01 Jul 2017

To see the full GST registrations and return filing status of Alcon Biosciences Private Limited, buy the company report.

Recent activity

Alcon Biosciences Private Limited has 9 board changes on record since 2003: 3 appointments and 6 cessations. The latest: Ashutosh Radheshyam Tripathi was appointed as Director on 01 Sep 2025.

AGM
Alcon Biosciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Appointed
Ashutosh Radheshyam Tripathi was appointed as Director.
Filing
Alcon Biosciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Charges
A charge with Others of Rs. 19.11 Cr registered on 27 Jun 1998 with Charge ID 90229362 was modified on 15 Jul 2024.
Ceased
Rakesh Ayodhyaprasad Pandey ceased to be Director.
Ceased
Kalpesh Sharma ceased to be Additional Director.
Appointed
Advait Jajodia was appointed as Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 2.70 Cr with Charge ID 100609238 was registered on 30 Aug 2022.
Charges
A charge with Others amounted to Rs. 2.41 Cr with Charge ID 100530433 was registered on 11 Jan 2022.
Charges
A charge registered on 04 Jan 2011 via Charge ID 10265344 with Union Bank Of India was fully satisfied on 07 Sep 2018.
Charges
A charge registered on 10 Oct 2009 via Charge ID 10188646 with Union Bank Of India was fully satisfied on 07 Sep 2018.
Ceased
Aadya Vishal Jajodia ceased to be Additional Director.

13 earlier events are in the company report.

Frequently asked questions

Alcon Biosciences is an active private limited company based in Mumbai, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 19 April 1982 (44+ years old) and is registered under CIN U24230MH1982PTC026953.

Alcon Biosciences has 3 current directors:

The latest financial statements of Alcon Biosciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Alcon Biosciences is 27AAACA5119P1ZH, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 24AAACA5119P1ZN (Gujarat).

The CIN (Corporate Identification Number) of Alcon Biosciences is U24230MH1982PTC026953. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Alcon Biosciences has 13 court cases on record: 11 filed by the company and 2 filed against it. 4 are pending. Most are in the district courts.

Alcon Biosciences was incorporated on 19 April 1982, making it 44+ years old. It is registered with the Registrar of Companies, Mumbai.

Alcon Biosciences has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹2.55 Cr; the latest was in March 2017.

The peers of Alcon Biosciences by revenue are Coral Drugs Private Limited, Sohan Healthcare Private Limited, Corey Organics Private Limited, Smruthi Organics Ltd, Quad Lifesciences Private Limited and 3 more, all in the Pharma industry (API Manufacturers, Biosciences), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Ashutosh Radheshyam Tripathi was appointed as Director on 01 Sep 2025. Rakesh Ayodhyaprasad Pandey ceased to be Director on 07 Nov 2023. Kalpesh Sharma ceased to be Additional Director on 29 Sep 2023. Alcon Biosciences has 9 board changes on record in total.

Yes, Alcon Biosciences is registered as an MSME under Udyam registration (number: UDYAM-GJ-25-0007199).

Alcon Biosciences has 11 MSME Form 1 returns on record between 2019 and 2024, listing 1,044 overdue payments to 111 micro and small suppliers. The latest return was filed on 30 Apr 2024.